Close

bluebird bio (BLUE) to Present Interim bb2121 Phase 1 Data in Multiple Myeloma at Upcoming Conference

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. SPY
3. SPOT
4. GM
5. AMZN
6. SHW
7. AAPL
8. IBM
9. MINN
10. NVDA


Go back to bluebird bio (BLUE) to Present Interim bb2121 Phase 1 Data in Multiple Myeloma at Upcoming Conference
BLUEBIRD BIO (NASDAQ: BLUE) Delayed: 0.97 +0.02 (2.11%)
Previous Close $0.95    52 Week High $95.28 
Open $0.96    52 Week Low $35.37 
Day High $1.05    P/E N/A 
Day Low $0.95    EPS $-1.81 
Volume 4,779,434